Document is current
Any future updates will be listed below
-
Authors
Suda, Goki
Sugiyama, Masaya
Hikita, Hayato
Nishio, Akira
Tatsumi, Tomohide
Takehara, Tetsuo
Murakawa, Miyako
Nakagawa, Mina
Asahina, Yasuhiro
Mizokami, Masashi
Kakisaka, Tatsuhiko
Sakamoto, Yuzuru
Taketomi, Akinobu
Miyanishi, Koji
Ueno, Yoshiyuki
Haga, Hiroaki
Maekawa, Shinya
Enomoto, Nobuyuki
Kurosaki, Masayuki
Kohjima, Motoyuki
Nakamuta, Makoto
Tanaka, Yasuhito
Yamamoto, Yoshiya
Baba, Masaru
Hanamatsu, Hisatoshi
Furukawa, Jun-Ichi
Ohara, Masatsugu
Kitagataya, Takashi
Kawagishi, Naoki
Nakai, Masato
Sho, Takuya
Ogawa, Koji
Sakamoto, Naoya
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development,Japan (JP25fk0210126, JP25fk0310545, JP24fk0210121, JP25fk0210142, JP25fk0310551, JP25fk0210123, JP25fk0310535, JP25fk0210157, JP25fk0310543, JP25fk0210172 JP25fk0210174, JP25fk0210143., JP25fk0210126, JP25fk0310545, JP24fk0210121, JP25fk0210142, JP25fk0310551, JP25fk0210123, JP25fk0310535, JP25fk0210157, JP25fk0310543, JP25fk0210172 JP25fk0210174, JP25fk0210143.)
- License Information
-
More Information
Article History
Received: 9 July 2025
Accepted: 24 August 2025
First Online: 24 September 2025
Declarations
:
: This study protocol was reviewed and approved by ethics committee of Hokkaido University Hospital (approval number 16–040). Written informed consent was obtained from participants at the time of study enrollment.
: Not applicable.
: Professor Naoya Sakamoto received lecture fees from Gilead Sciences, grants and endowments from MSD K. K and Chugai Pharmaceutical Co. Ltd., and a research grant from AbbVie Inc. Dr. Goki Suda received research grants from Gilead Sciences. Professor Tetsuo Takehara received lecture fees from Gilead Sciences, Chugai Pharmaceutical Co. Ltd., and AbbVie Inc, and grants from Gilead Sciences, Chugai Pharmaceutical Co. Ltd., and AbbVie Inc. Dr. Hayato Hikita received lecture fees from Gilead Sciences, Chugai Pharmaceutical Co. Ltd., and AbbVie Inc. The other authors declare no competing interests.
